Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

57
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
57
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Usefulness of Clot Waveform Analysis-Activated Thromboplastin Time (APTT) for Diagnosing Thrombotic Diseases.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026
Same author

Recognizing Coagulation Disorders in Sepsis in the Emergency Room: A Narrative Review.

Journal of clinical medicine·2026
Same author

Evaluation of Autoimmune FVIII Inhibitor Using Clot Waveform Analysis in Emicizumab-Treated Patients.

Journal of clinical medicine·2026
Same author

Diagnostic and Prognostic Evaluation of Disseminated Intravascular Coagulation Using the Disseminated Intravascular Coagulation Index.

Journal of clinical medicine·2025
Same author

Factors influencing antithrombin activity following supplementation in sepsis-associated disseminated intravascular coagulation.

Thrombosis journal·2025
Same author

Evaluation of Deficiency and Excessive Condition of Thrombin Burst Using Laboratory Tests.

Thrombosis and haemostasis·2025

Related Experiment Video

Updated: Oct 13, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K

The Reevaluation of Thrombin Time Using a Clot Waveform Analysis.

Hideo Wada1, Yuhuko Ichikawa2, Minoru Ezaki2

  • 1Department of General and Laboratory Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-0885, Japan.

Journal of Clinical Medicine
|November 13, 2021
PubMed
Summary

Clot waveform analysis of thrombin time (CWA-TT) shows abnormalities in clotting factor deficiencies and is influenced by platelets. This suggests CWA-TT may be a valuable tool for diagnosing hemostatic abnormalities.

Keywords:
CWAplateletthrombin burstthrombin time

More Related Videos

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.2K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.9K

Related Experiment Videos

Last Updated: Oct 13, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
06:28

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

6.9K
Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.2K
An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

2.9K

Area of Science:

  • Hematology
  • Coagulation science
  • Diagnostic assays

Background:

  • Thrombin burst is a key coagulation mechanism, but clinical data from routine assays are limited.
  • Clot waveform analysis (CWA) offers a potential method to evaluate thrombin time (TT).

Purpose of the Study:

  • To evaluate the utility of CWA for assessing thrombin time (TT) as a diagnostic tool.
  • To investigate the impact of clotting factor deficiencies and platelet concentration on CWA-TT.

Main Methods:

  • Thrombin time (TT) was assessed using CWA with low thrombin concentrations.
  • Evaluations included plasma deficient in clotting factors, calibration plasma, platelet-poor plasma (PPP), and platelet-rich plasma (PRP).
  • Samples were obtained from healthy volunteers, thrombocytopenia patients, and malignant disease patients.

Main Results:

  • CWA-TT was abnormal in plasma with clotting factor deficiencies, particularly Factor VIII deficiency.
  • Platelet-rich plasma (PRP) showed distinct waveform patterns compared to platelet-poor plasma (PPP).
  • The second peak of the first derivative (1st DP-2) was altered in thrombocytopenia and malignant disease patient samples.

Conclusions:

  • CWA-TT demonstrates abnormalities in various clotting factor deficiencies.
  • Platelets significantly influence CWA-TT results.
  • CWA-TT shows promise as a diagnostic test for hemostatic abnormalities.